Sign in or create an account to add this stock to your watchlist.
About Amedica (NASDAQ:AMDA)
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. The company offers Valeo silicon nitride spinal fusion devices for use in the cervical and thoracolumbar areas of spine; and a line of non-silicon nitride spinal fixation products to address spinal deformity and degenerative conditions. It also develops femoral heads for use in total hip replacements; and femoral condyle components for use in total knee replacements. The company markets and sells its products to surgeons and hospitals directly, as well as through a network of independent sales distributors. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AMDA
CUSIPN/A
Phone801-839-3500
Debt
Debt-to-Equity RatioN/A
Current Ratio0.45
Quick Ratio0.30
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$11.22 million
Price / Sales0.44
Cash FlowN/A
Price / CashN/A
Book Value$1.37 per share
Price / Book0.82
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-9,320,000.00
Net Margins-118.90%
Return on Equity-151.88%
Return on Assets-71.28%
Miscellaneous
Employees33
Outstanding Shares4,360,000
Amedica (NASDAQ:AMDA) Frequently Asked Questions
What is Amedica's stock symbol?
Amedica trades on the NASDAQ under the ticker symbol "AMDA."
When did Amedica's stock split? How did Amedica's stock split work?
Amedica's stock reverse split on Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 9th 2017. An investor that had 100 shares of Amedica stock prior to the reverse split would have 8 shares after the split.
How were Amedica's earnings last quarter?
Amedica (NASDAQ:AMDA) released its quarterly earnings data on Tuesday, November, 21st. The medical equipment provider reported ($0.93) EPS for the quarter, topping analysts' consensus estimates of ($0.94) by $0.01. The medical equipment provider had revenue of $2.96 million for the quarter. Amedica had a negative net margin of 118.90% and a negative return on equity of 151.88%. View Amedica's Earnings History.
When is Amedica's next earnings date?
Who are some of Amedica's key competitors?
Some companies that are related to Amedica include Cytori Therapeutics (CYTX), InVivo Therapeutics (NVIV), Alliqua BioMedical (ALQA), United American Healthcare (UAHC), Neurometrix (NURO), Atossa Genetics (ATOS), Biostage (BSTG), Regenicin (RGIN), STRATA Skin Sciences (SSKN), Avinger (AVGR), Cytocore common stock (MDIT), OxySure (OXYS), Encision (ECIA), Delcath Systems (DCTHD) and TearLab (TEAR).
Who are Amedica's key executives?
Amedica's management team includes the folowing people:
- Dr. B. Sonny Bal, Chairman, Pres & CEO (Age 56)
- Mr. Bryan J. McEntire, Chief Technology Officer (Age 66)
- Mr. David O'brien, VP of Operations
- Mr. Dana Lyons, VP of Sales and Marketing
- Mr. Clay Smith, Sr. Director of Global Marketing
Has Amedica been receiving favorable news coverage?
Media coverage about AMDA stock has trended somewhat negative this week, according to Accern. The research firm identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Amedica earned a news sentiment score of -0.01 on Accern's scale. They also gave news coverage about the medical equipment provider an impact score of 47.16 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
How do I buy shares of Amedica?
Shares of AMDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Amedica's stock price today?
One share of AMDA stock can currently be purchased for approximately $1.13.
How big of a company is Amedica?
Amedica has a market capitalization of $4.89 million and generates $11.22 million in revenue each year. Amedica employs 33 workers across the globe.
How can I contact Amedica?
Amedica's mailing address is 1885 WEST 2100 SOUTH, SALT LAKE CITY UT, 84119. The medical equipment provider can be reached via phone at 801-839-3500 or via email at [email protected]
MarketBeat Community Rating for Amedica (AMDA)
MarketBeat's community ratings are surveys of what our community members think about Amedica and other stocks. Vote "Outperform" if you believe AMDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMDA will underperform the S&P 500 over the long term. You may vote once every thirty days.
Amedica (NASDAQ:AMDA) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for Amedica in the last 12 months. There are currently 2 hold ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.00 | 2.00 | 2.00 | 2.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | $60.00 | $60.00 | $60.00 |
| Price Target Upside: | N/A | 2,207.69% upside | 1,654.39% upside | 18,361.54% upside |
Amedica (NASDAQ:AMDA) Consensus Price Target History
Amedica (NASDAQ:AMDA) Analyst Ratings History
Show:
(Data available from 5/23/2016 forward)
Amedica (NASDAQ:AMDA) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Amedica (NASDAQ AMDA) News Headlines
| Source: |
|
Amedica (NASDAQ:AMDA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Amedica (NASDAQ:AMDA) Income Statement, Balance Sheet and Cash Flow Statement
Amedica (NASDAQ AMDA) Stock Chart for Wednesday, May, 23, 2018
Loading chart…
